Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03120819 · ClinicalTrials.gov registry record · NA

Exercise Information for Women With Cancer

A NA study, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
95
Enrollment target

NCT03120819: Completed NA study, sponsored by Oregon Health and Science University.

NCT03120819 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 95 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03120819, a NA study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target

Study Summary

Fatigue is a troublesome symptom for breast cancer patients, which might be mitigated with exercise. Cancer patients often prefer their oncologist recommend an exercise program, yet a recommendation alone may not be enough to change behavior. Our study will determine whether adding an exercise DVD to an oncologist's recommendation to exercise led to better outcomes than a recommendation alone.

Primary Outcome

Fatigue will be measured with the Brief Profile of Mood States Fatigue subscale

Interventions

  • BEHAVIORAL Oncologist Recommendation
  • BEHAVIORAL Oncologist Recommendation + DVD

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2010-08-01
Est. Completion 2017-04-01
Phase NA

What the finished NCT03120819 record still lists

NCT03120819 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Oncologist Recommendation is the first listed.

NCT03120819 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03120819 about?

NCT03120819 is a clinical study titled "Exercise Information for Women With Cancer". Fatigue is a troublesome symptom for breast cancer patients, which might be mitigated with exercise. Cancer patients often prefer their oncologist recommend an exercise program, yet a recommendation alone may not be enough to change behavior. Our study will determine whether adding an exercise DVD t...

What is the current status of trial NCT03120819?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2010-08-01. Estimated completion is 2017-04-01.

What interventions are being tested in trial NCT03120819?

The interventions under investigation include: Oncologist Recommendation (BEHAVIORAL), Oncologist Recommendation + DVD (BEHAVIORAL).

Who is sponsoring clinical trial NCT03120819?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03120819's enrollment target sits among peer trials

95 931st of 2000 higher than 1,066 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03120819, the US trial registry maintained by the National Library of Medicine. NCT03120819 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.